Loading organizations...

Software to launch and integrate genetics into clinical care
Nest Genomics has raised $8.5M across 1 funding round.
Key people at Nest Genomics.
Nest Genomics was founded in 2022 by Guy Snir (Founder/COO) and Moran Snir (Founder).
Nest Genomics has raised $8.5M in total across 1 funding round.
Nest is a lab-agnostic, comprehensive solution for organizations to launch and implement large-scale genomic programs. The platform includes the ability to triage, consent, and counsel patients for genetic testing, provide EMR-integrated clinical decision support for providers managing patients with genetic results, and manage patients’ clinical needs across the continuum of care.
Nest Genomics is a software company that builds a comprehensive platform to integrate genomic information into clinical care workflows, enabling healthcare organizations to launch, implement, and scale genomic programs efficiently. Their platform supports patient identification, risk assessment, test ordering, clinical decision support, and patient education at the point of care, reducing the time from referral to results by nearly threefold. Nest primarily serves health systems, clinics, labs, and patient advocacy groups, addressing the challenge of incorporating rapidly expanding genomic data into everyday healthcare to improve personalized medicine and patient outcomes[1][2][3].
Founded in 2021 by Moran Shochat Snir and a team of repeat genomics entrepreneurs, Nest Genomics emerged from the founders’ experience in building genomic software products like the GIA chatbot and Genometer. The idea arose from the need to make genetic information more accessible and actionable within clinical workflows, overcoming barriers in healthcare systems that hinder the effective use of genomic data. Early traction includes partnerships with organizations like Genome Medical to expand access to genetic services and streamline genetic counseling and testing through integrated digital workflows[1][3][4].
Nest Genomics rides the wave of precision medicine and digital health transformation, addressing a critical bottleneck in healthcare: the integration of complex genomic data into routine clinical care. The timing is favorable due to increasing genomic testing availability, growing demand for personalized medicine, and healthcare systems’ push for data-driven decision-making. Market forces such as regulatory support for genomic testing, advances in AI for genomics, and rising patient awareness further accelerate adoption. Nest’s platform not only facilitates genomic program scalability but also influences the ecosystem by enabling healthcare providers to deliver more precise, actionable care, thus advancing the broader goal of genomics-driven medicine[2][3][4].
Looking ahead, Nest Genomics is positioned to expand its footprint by deepening integrations with more EMRs and healthcare systems, enhancing AI-driven clinical decision support, and broadening patient engagement tools. Trends shaping their journey include the continued democratization of genomic testing, regulatory incentives for precision medicine, and the rise of telehealth genetic services. As personalized medicine becomes standard care, Nest’s influence will likely grow, driving more healthcare organizations to adopt genomic programs and improving outcomes at scale. Their mission to make genetic information part of everyday health aligns with the future of healthcare, where genomics is integral to diagnosis, treatment, and prevention[3][4][6].
Key people at Nest Genomics.
Nest Genomics was founded in 2022 by Guy Snir (Founder/COO) and Moran Snir (Founder).
Nest Genomics has raised $8.5M in total across 1 funding round.
Nest Genomics's investors include Karen Page, Anne Wojcicki, Deneen Vojta, M.D., Arkin Digital Health, Casdin Capital, Data Collective, iAngels, LionBird, Maven Ventures, Samsung Next, Y Combinator.
Nest Genomics has raised $8.5M across 1 funding round. Most recently, it raised $8.5M Nest Genomics (YC W22) - Seed in January 2023.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 10, 2023 | $8.5M Nest Genomics (YC W22) - Seed | Karen Page | Anne Wojcicki, Deneen Vojta, M.D., Arkin Digital Health, Casdin Capital, Data Collective, iAngels, LionBird, Maven Ventures, Samsung Next, Y Combinator |